Robert Wasserman
Stock Analyst at Benchmark
(4.33)
# 401
Out of 4,502 analysts
85
Total ratings
53.25%
Success rate
16.38%
Average return
Main Sectors:
19 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| INTS Intensity Therapeutics | Reiterates: Speculative Buy | $12 | $4.85 | +147.42% | 6 | Jul 11, 2024 | |
| EBS Emergent BioSolutions | Reiterates: Buy | $8 | $13.80 | -42.03% | 14 | Jul 3, 2024 | |
| LGND Ligand Pharmaceuticals | Reiterates: Buy | $95 | $106.01 | -10.39% | 7 | Jun 28, 2024 | |
| HALO Halozyme Therapeutics | Maintains: Buy | $50 → $60 | $55.97 | +7.20% | 6 | Jun 25, 2024 | |
| PRLB Proto Labs | Reiterates: Buy | $45 | $34.41 | +30.78% | 6 | May 29, 2024 | |
| NEPH Nephros | Reiterates: Speculative Buy | $5 | $2.21 | +126.24% | 2 | May 15, 2024 | |
| OABI OmniAb | Reiterates: Buy | $8 | $4.80 | +66.67% | 5 | May 14, 2024 | |
| BLFS BioLife Solutions | Upgrades: Buy | $25 | $23.03 | +8.55% | 5 | May 13, 2024 | |
| ITGR Integer Holdings | Reiterates: Buy | $130 | $115.68 | +12.38% | 5 | May 10, 2024 | |
| CDXS Codexis | Reiterates: Buy | $9 | $3.65 | +146.58% | 5 | May 3, 2024 | |
| TECH Bio-Techne | Reiterates: Buy | $95 | $78.67 | +20.76% | 4 | May 2, 2024 | |
| IPA ImmunoPrecise Antibodies | Reiterates: Speculative Buy | $5 | $0.84 | +497.73% | 4 | Mar 15, 2024 | |
| ATHE Alterity Therapeutics | Reiterates: Speculative Buy | $4 | $1.60 | +150.00% | 1 | Mar 7, 2024 | |
| PCSA Processa Pharmaceuticals | Reiterates: Speculative Buy | $4 | $1.68 | +138.10% | 1 | Mar 6, 2024 | |
| ABCL AbCellera Biologics | Upgrades: Buy | n/a | $3.10 | - | 3 | Feb 22, 2024 | |
| RGEN Repligen | Downgrades: Hold | n/a | $132.36 | - | 2 | Dec 4, 2023 | |
| ANEB Anebulo Pharmaceuticals | Reiterates: Speculative Buy | $8 | $2.20 | +263.64% | 4 | Oct 3, 2023 | |
| FBIO Fortress Biotech | Reiterates: Speculative Buy | $75 | $2.60 | +2,784.62% | 2 | Apr 6, 2023 | |
| DHR Danaher | Downgrades: Hold | n/a | $270.09 | - | 3 | Oct 24, 2022 |
Intensity Therapeutics
Jul 11, 2024
Reiterates: Speculative Buy
Price Target: $12
Current: $4.85
Upside: +147.42%
Emergent BioSolutions
Jul 3, 2024
Reiterates: Buy
Price Target: $8
Current: $13.80
Upside: -42.03%
Ligand Pharmaceuticals
Jun 28, 2024
Reiterates: Buy
Price Target: $95
Current: $106.01
Upside: -10.39%
Halozyme Therapeutics
Jun 25, 2024
Maintains: Buy
Price Target: $50 → $60
Current: $55.97
Upside: +7.20%
Proto Labs
May 29, 2024
Reiterates: Buy
Price Target: $45
Current: $34.41
Upside: +30.78%
Nephros
May 15, 2024
Reiterates: Speculative Buy
Price Target: $5
Current: $2.21
Upside: +126.24%
OmniAb
May 14, 2024
Reiterates: Buy
Price Target: $8
Current: $4.80
Upside: +66.67%
BioLife Solutions
May 13, 2024
Upgrades: Buy
Price Target: $25
Current: $23.03
Upside: +8.55%
Integer Holdings
May 10, 2024
Reiterates: Buy
Price Target: $130
Current: $115.68
Upside: +12.38%
Codexis
May 3, 2024
Reiterates: Buy
Price Target: $9
Current: $3.65
Upside: +146.58%
Bio-Techne
May 2, 2024
Reiterates: Buy
Price Target: $95
Current: $78.67
Upside: +20.76%
ImmunoPrecise Antibodies
Mar 15, 2024
Reiterates: Speculative Buy
Price Target: $5
Current: $0.84
Upside: +497.73%
Alterity Therapeutics
Mar 7, 2024
Reiterates: Speculative Buy
Price Target: $4
Current: $1.60
Upside: +150.00%
Processa Pharmaceuticals
Mar 6, 2024
Reiterates: Speculative Buy
Price Target: $4
Current: $1.68
Upside: +138.10%
AbCellera Biologics
Feb 22, 2024
Upgrades: Buy
Price Target: n/a
Current: $3.10
Upside: -
Repligen
Dec 4, 2023
Downgrades: Hold
Price Target: n/a
Current: $132.36
Upside: -
Anebulo Pharmaceuticals
Oct 3, 2023
Reiterates: Speculative Buy
Price Target: $8
Current: $2.20
Upside: +263.64%
Fortress Biotech
Apr 6, 2023
Reiterates: Speculative Buy
Price Target: $75
Current: $2.60
Upside: +2,784.62%
Danaher
Oct 24, 2022
Downgrades: Hold
Price Target: n/a
Current: $270.09
Upside: -